Karin K. Shih

Karin K. Shih

Oncology
136-17 39th Avenue
Suite 1A
Flushing, NY 11354

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trial.

Maintenance with niraparib in patients with stage III, stage IV, chemo-naïve recurrent or platinum-sensitive recurrent uterine serous carcinoma: study protocol for a phase II clinical trial.

Journal: BMJ open
Published: June 05, 2025

Updates in Hormone Replacement Therapy for Survivors of Gynecologic Cancers.

Updates in Hormone Replacement Therapy for Survivors of Gynecologic Cancers.

Journal: Current treatment options in oncology
Published: February 03, 2025

Endometrial cancer in a transgender male: A rare case and review of the literature.

Endometrial cancer in a transgender male: A rare case and review of the literature.

Journal: Gynecologic oncology reports
Published: March 28, 2023

Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?

Is minimally invasive surgery for clinical stage I uterine carcinosarcoma safe?

Journal: Journal of robotic surgery
Published: August 12, 2021

Yolk sac tumor of the endometrium in a post-menopausal woman: Case report and review of the literature.

Yolk sac tumor of the endometrium in a post-menopausal woman: Case report and review of the literature.

Journal: Gynecologic oncology reports
Published: December 30, 2020

Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience.

Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience.

Journal: Diagnostics (Basel, Switzerland)
Published: October 23, 2019

Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy.

Impact of postoperative intensity-modulated radiation therapy (IMRT) on the rate of bowel obstruction in gynecologic malignancy.

Journal: Gynecologic oncology
Published: June 14, 2016

Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.

Platinum and PARP Inhibitor Resistance Due to Overexpression of MicroRNA-622 in BRCA1-Mutant Ovarian Cancer.

Journal: Cell reports
Published: September 28, 2015

Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.

Molecular subtypes of uterine leiomyosarcoma and correlation with clinical outcome.

Journal: Neoplasia (New York, N.Y.)
Published: October 01, 2014

Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.

Postoperative pelvic intensity-modulated radiotherapy in high risk endometrial cancer.

Journal: Gynecologic oncology
Published: October 10, 2012

Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation.

Pelvic insufficiency fractures in patients with cervical and endometrial cancer treated with postoperative pelvic radiation.

Journal: Gynecologic oncology
Published: October 01, 2012

Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.

Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer.

Journal: Gynecologic oncology
Published: August 21, 2012
Showing 1-12 of 12

Last Updated: 09/26/2026